EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent®(alirocumab)

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent in...
Continue Reading →
news

Breast cancer death rate drops by almost 40 percent in U.S.

Breast cancer is the most common cancer diagnosed in U.S. women and the second-leading cause of death after lung cancer. About 252,000 new cases of breast cancer are ...
Continue Reading →
news

Researchers rattled by the revised definition of clinical trials

The new definition’s interpretation of “intervention” and “outcome” could apply even to studies of basic biological mechanisms.   The U.S. National Institutes o...
Continue Reading →
Asia Pacific

Dornier MedTech opens Asia Pacific Headquarters & Global Clinical Innovation Centre in Singapore

The Centre represents one of the first medical technology innovation centres in Singapore to lead a global clinical research, regulatory and commercialisation strateg...
Continue Reading →
news

Companies Increase Adoption of Veeva Vault CTMS to Streamline Clinical Processes and Improve Visibility Across Studies

More life sciences companies are bringing together clinical processes and information to streamline trial management Veeva Systems (NYSE:VEEV) announced that Veeva Va...
Continue Reading →
news

FDA Fast Track designations reach 20th year

Mixed experience but no changes in the forecast Twenty years after its inception, the FDA’s Fast Track designation program is going strong, with many signs that it ha...
Continue Reading →
Asia Pacific

AMRI names Joseph D. Sangregorio SVP and chief human resources officer

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life f...
Continue Reading →
Europe

New artificial skin trials offer hope to acid attack victims

  The horrific increase in the number of acid attacks in the UK has given medical research trust RAFT even more reason to back its latest next generation artifi...
Continue Reading →
Europe

Amgen and CytomX Therapeutics announce strategic collaboration in immuno-oncology

Amgen (NASDAQ:AMGN) and CytomX Therapeutics, Inc., (NASDAQ:CTMX) today announced that the companies have entered into a strategic collaboration in immuno-oncology. Th...
Continue Reading →
Europe

Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies

 Immatics, a leading company in the field of cancer immunotherapy, today announced the completion of its Series E financing, raising $58 million. The Series E funding...
Continue Reading →
Quotient